Appili Therapeutics Inc (APLI) — Cash Flow Quality Index

Latest as of March 2025: 4.54x

Appili Therapeutics Inc (APLI) has a Cash Flow Quality Index of 4.54x as of March 2025. Operating cash flow of CA$1.03 Million exceeds net income of CA$228.05K, indicating high earnings quality where cash backs reported profits. Explore Appili Therapeutics Inc operating cash flow efficiency to assess how effectively this company generates cash.

Cash Flow Quality Index

4.54x

Operating CF / Net Income

Operating Cash Flow

CA$1.03 Million

CAD

Net Income

CA$228.05K

CAD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Appili Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Appili Therapeutics Inc. For live market cap and the full company financial profile, see APLI market cap.

Year	Quality Index	Operating CF (CAD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.